{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:29:25Z","timestamp":1783103365069,"version":"3.54.6"},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T00:00:00Z","timestamp":1491868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T00:00:00Z","timestamp":1491868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hepatobiliary Pancreat Sci"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1002\/jhbp.439","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T18:22:43Z","timestamp":1487096563000},"page":"262-267","source":"Crossref","is-referenced-by-count":19,"title":["Gemcitabine-cisplatin versus gemcitabine-oxaliplatin doublet chemotherapy in advanced gallbladder cancers: a match pair analysis"],"prefix":"10.1002","volume":"24","author":[{"given":"Anant","family":"Ramaswamy","sequence":"first","affiliation":[{"name":"Department of Medical Oncology; Tata Memorial Hospital; Mumbai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Ostwal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Tata Memorial Hospital; Mumbai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Pinninti","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Tata Memorial Hospital; Mumbai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhana","family":"Kannan","sequence":"additional","affiliation":[{"name":"Department of Statistics; Advanced Centre for Treatment; Research and Education in Cancer; Mumbai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhat","family":"Bhargava","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Tata Memorial Hospital; Mumbai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitali","family":"Nashikkar","sequence":"additional","affiliation":[{"name":"Department of GI DMG; Tata Memorial Hospital; Mumbai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Mirani","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Tata Memorial Hospital; Mumbai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shripad","family":"Banavali","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Tata Memorial Hospital; Mumbai India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,4,11]]},"reference":[{"key":"10.1002\/jhbp.439-BIB0001|jhbp439-cit-0001","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1002\/jhbp.439-BIB0002|jhbp439-cit-0002","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1200\/JCO.2010.29.3605","article-title":"Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study","volume":"28","author":"Sharma","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1002\/jhbp.439-BIB0003|jhbp439-cit-0003","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/cam4.299","article-title":"Cisplatin\/gemcitabine or oxaliplatin\/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review","volume":"3","author":"Fiteni","year":"2014","journal-title":"Cancer Med"},{"key":"10.1002\/jhbp.439-BIB0004|jhbp439-cit-0004","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/sj.bjc.6603648","article-title":"Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials","volume":"96","author":"Eckel","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1002\/jhbp.439-BIB0005|jhbp439-cit-0005","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1002\/jhbp.439-BIB0006|jhbp439-cit-0006","first-page":"1","article-title":"Trends in incidence of gallbladder cancer - Indian scenario","volume":"1","author":"Murthy","year":"2011","journal-title":"Gastrointest Cancer Targets Ther"},{"key":"10.1002\/jhbp.439-BIB0007|jhbp439-cit-0007","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1002\/jhbp.439-BIB0008|jhbp439-cit-0008","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1470-2045(14)70212-8","article-title":"Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial","volume":"15","author":"Malka","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1002\/jhbp.439-BIB0009|jhbp439-cit-0009","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1172\/JCI117840","article-title":"Cisplatin-associated anemia: an erythropoietin deficiency syndrome","volume":"95","author":"Wood","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1002\/jhbp.439-BIB0010|jhbp439-cit-0010","doi-asserted-by":"crossref","first-page":"e176182","DOI":"10.1155\/2014\/176182","article-title":"Prevalence and severity of anaemia stratified by age and gender in rural India","volume":"2014","author":"Alvarez-Uria","year":"2014","journal-title":"Anemia"},{"key":"10.1002\/jhbp.439-BIB0011|jhbp439-cit-0011","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4103\/0971-5851.195745","article-title":"Oxaliplatin-related neuropathy in Indian patients - no difference between generic and original molecules","volume":"37","author":"Sirohi","year":"2016","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1002\/jhbp.439-BIB0012|jhbp439-cit-0012","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","article-title":"Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study","volume":"15","author":"Andr\u00e9","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1002\/jhbp.439-BIB0013|jhbp439-cit-0013","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjc.6605779","article-title":"Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan","volume":"103","author":"Okusaka","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1002\/jhbp.439-BIB0014|jhbp439-cit-0014","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-016-9885-6","article-title":"A cost-effectiveness analysis of gemcitabine plus cisplatin versus gemcitabine alone for treatment of advanced biliary tract cancer in Japan","author":"Tsukiyama","year":"2016","journal-title":"J Gastrointest Cancer"},{"key":"10.1002\/jhbp.439-BIB0015|jhbp439-cit-0015","doi-asserted-by":"crossref","first-page":"abstr 4077.","DOI":"10.1200\/JCO.2016.34.15_suppl.4077","article-title":"Final results of a phase III randomized controlled trial comparing modified gemcitabine + oxaliplatin (mGEMOX) to gemcitabine+ cisplatin in management of unresectable gall bladder cancer (GBC)","volume":"34","author":"Sharma","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Journal of Hepato-Biliary-Pancreatic Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjhbp.439","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jhbp.439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T10:58:37Z","timestamp":1625482717000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jhbp.439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1002\/jhbp.439","archive":["Portico"],"relation":{},"ISSN":["1868-6974"],"issn-type":[{"value":"1868-6974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,11]]}}}